These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35360506)

  • 1. Ovarian Sensitivity Decreased Significantly in Patients With Insulin Resistance Undergoing
    Zheng Y; Pan Y; Li P; Wang Z; Wang Z; Shi Y
    Front Physiol; 2021; 12():809419. PubMed ID: 35360506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acupuncture combined with medication improves endocrine hormone levels and ovarian reserve function in poor ovarian response patients undergoing in vitro fertilization-embryo transplantation].
    Dong XL; Ran JK; Zhang HJ; Chen K; Li HX
    Zhen Ci Yan Jiu; 2019 Aug; 44(8):599-604. PubMed ID: 31475495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do basal Luteinizing Hormone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio Have Significance in Prognosticating the Outcome of
    Singh N; Mishra N; Dogra Y
    J Hum Reprod Sci; 2021; 14(1):21-27. PubMed ID: 34083988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing
    Zhu X; Ye H; Ye J; Fu Y
    Ann Transl Med; 2021 Mar; 9(5):387. PubMed ID: 33842608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The homeostasis model assessment of insulin resistance is a judgment criterion for metformin pre-treatment before IVF/ICSI and embryo transfer cycles in patients with polycystic ovarian syndrome.
    Gao R; Qin L; Li Z; Min W
    Front Endocrinol (Lausanne); 2023; 14():1106276. PubMed ID: 36843612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of insulin resistance and obesity on intracytoplasmic sperm injection outcomes in young women with polycystıc ovary syndrome.
    Cakiroglu Y; Doger E; Vural F; Kopuk SY; Vural B
    North Clin Istanb; 2017; 4(3):218-224. PubMed ID: 29270569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
    Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
    J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer.
    Lin HY; Li Y; Wang WJ; Qiu Q; Zhang QX; Li Y
    Chin Med J (Engl); 2019 Jun; 132(12):1448-1453. PubMed ID: 31205103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ovarian Sensitivity Index (OSI) Significantly Correlates with Ovarian Reserve Biomarkers, Is More Predictive of Clinical Pregnancy than the Total Number of Oocytes, and Is Consistent in Consecutive IVF Cycles.
    Revelli A; Gennarelli G; Biasoni V; Chiadò A; Carosso A; Evangelista F; Paschero C; Filippini C; Benedetto C
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32570935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Anti-Müllerian Hormone and
    Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
    Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.